What is the prevalence of Melorheostosis?

Melorheostosis is an extremely rare, non-hereditary sclerosing bone dysplasia with an estimated prevalence of less than 1 in 1,000,000 people worldwide. Because the condition is often asymptomatic or misdiagnosed as other bone disorders, true prevalence is likely higher than currently documented in medical literature.

What is the estimated prevalence and incidence of Melorheostosis?

Melorheostosis is classified as an ultra-rare disease. Due to its sporadic nature and the frequent absence of clinical symptoms, accurate epidemiological data is difficult to capture. According to Orphanet, the prevalence is estimated to be less than 1 per 1,000,000, though this figure likely underestimates the true number of cases. There is no reliable data for annual incidence, as many individuals remain undiagnosed until adulthood when incidental findings appear on imaging.

Does Melorheostosis affect specific demographics differently?

Clinical observations suggest that Melorheostosis affects both males and females equally, with no clear gender predilection. While it can be diagnosed at any stage of life, the condition most commonly presents in early adulthood or late childhood. Key characteristics regarding its presentation include:

• Age of Onset: Most cases are identified before age 20, though symptoms may remain dormant for years.


• Geographic/Ethnic Distribution: There is no evidence suggesting higher prevalence in any specific geographic region or ethnic population.


• Diagnostic Challenges: The "dripping candle wax" appearance on X-rays is pathognomonic for Melorheostosis, yet its rarity often leads to delays in diagnosis.

Why is accurate data for Melorheostosis so limited?

The rarity of Melorheostosis makes large-scale population studies impossible. Many patients experience mild or localized disease that never requires medical intervention, meaning they never enter the clinical record. The DiseaseMaps.org community provides a vital, real-world perspective, currently connecting 65 people with Melorheostosis who share their lived experiences, which helps researchers better understand the symptomatic spectrum beyond clinical textbooks.

Next steps

• Consult with a musculoskeletal radiologist or an orthopedic specialist familiar with rare bone dysplasias.


• Join the Melorheostosis community at DiseaseMaps.org to connect with others and share experiences.


• Request a referral to a metabolic bone disease center if you are experiencing chronic pain or limited mobility.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with a qualified healthcare professional regarding your specific condition.

References

• Orphanet: Rare bone disease database (ORPHA:565).


• NIH Genetic and Rare Diseases Information Center (GARD).


• OMIM (Online Mendelian Inheritance in Man): Entry #155950.


• The Melorheostosis Association (patient advocacy resources).